Elsevier

Pediatric Neurology

Volume 49, Issue 4, October 2013, Pages 232-236
Pediatric Neurology

Topical Review
Autism Spectrum Disorders and Inborn Errors of Metabolism: An Update

https://doi.org/10.1016/j.pediatrneurol.2013.05.013Get rights and content

Abstract

Background

Autism spectrum disorder is characterized by social communicative deficits with restricted interests occurring in about 1% of the population. Although its exact cause is not known, several factors have been implicated in its etiology, including inborn errors of metabolism. Although relatively uncommon, these disorders frequently occur in countries with high rates of consanguinity and are often associated with behavioral problems, such as hyperactivity and aggression. The aim of this review is to examine the association of autism with these conditions.

Method

A computer-assisted search was performed to identify the most common inborn errors of metabolism associated with autism.

Results

The following disorders were identified: phenylketonuria, glucose-6-phosphatase deficiency, propionic acidemia, adenosine deaminase deficiency, Smith–Lemli–Opitz syndrome and mitochondrial disorders, and the recently described branched chain ketoacid dehydrogenase kinase deficiency.

Conclusion

The risk of autistic features is increased in children with inborn errors of metabolism, especially in the presence of cognitive and behavioral deficits. We propose that affected children should be screened for autism.

Introduction

Autism spectrum disorder (ASD) is a behavioral syndrome characterized by social communication deficits with rigid restricted interests, occurring in about 1% of the population.1, 2 Although ASD and autism are often used interchangeably, the former more correctly refers to a group of disorders of varying degrees of severity. At least 10% of patients with ASD suffer from comorbid disorders, such as tuberous sclerosis and fragile X syndrome.3

ASD can also occur with inborn errors of metabolism, sometimes referred to as inherited metabolic disorders, which occur in 1 in 800 live births.4 These conditions, which have become increasingly important because of the progress made in their diagnosis and management,5 occur when an enzyme or a transport protein deficiency causes a block in a metabolic pathway resulting either in a harmful accumulation of the substrate behind the block or in a deficiency of the product. They can be divided into acute and chronic categories. The former group usually begins in the first 2-3 years of life and may present in metabolic crisis (intoxication), whereas the latter may come to medical attention at any time and have a more insidious course. Metabolic disorders with intoxication often present with acute encephalopathy associated with acidosis, hyperammonemia, and/or hypoglycemia.5 Several behavioral and neuropsychiatric abnormalities can occur in children with metabolic disorders.6 These stem from the involvement of the central nervous system and include learning disability, social deficits, hyperactivity, aggression, catatonia, psychosis, and depression.7 Because most metabolic disorders are autosomal recessive,8 they are more common in countries with high rates of consanguinity, where they are associated with a significant degree of morbidity and mortality.9

Increased awareness of both autism and of inherited metabolic disorders has increased the focus on the comorbidity between them. Although, the exact rate of autism in patients with inherited metabolic disorders is not known, the rate of the latter in patients with autism is said to be around 2%. For example, in a study of 222 Greek children with autism, 2.7% suffered from a metabolic disorder.10 However, given that the correct diagnosis of an inborn error of metabolism requires both clinical and technological expertise, this figure is probably closer to 5%.11

There have been no recent reviews of the association of autism with metabolic disorders since the last review by Manzi and colleagues.12 Since then, several new reports have described the occurrence of autism in patients with inherited metabolic disorders. For example, a novel metabolic entity (branched chain ketoacid dehydrogenase kinase deficiency) was recently described in multiple consanguineous families with autism, epilepsy, and intellectual disability.13 The aim of this review is to describe the association between the two conditions with particular reference to publications since the review by Manzi et al.12

Section snippets

Method

A computer-assisted PubMed search was performed with the keywords “autism,” “autism spectrum disorders,” “pervasive developmental disorders,” “metabolic diseases,” “metabolic disorders,” and “inborn errors of metabolism.” Through cross-references, reviews and book chapters were also examined. The following disorders were most commonly identified.

Assessment and treatment

Clinicians working in countries with a high prevalence of recessive conditions should rule out autism in patients with inborn errors of metabolism, especially in children with behavioral problems. Common behavioral problems that suggest a need for screening for autism include speech and language abnormalities, hyperactivity and impulsivity, difficulty in interacting with peers, suggestion of intellectual disability, and presence of excessive interests and ritualistic behaviors. There is a

Conclusion

Autistic symptoms occur in a variety of inborn errors of metabolism. These are more likely to occur in certain countries, such as in the Middle East, where recessive conditions are common because of consanguinity. The association of autism with metabolic disorders underscores that autism can be the end result of a variety of insults and injuries. The severity of the autistic symptoms varies with the timing of the diagnosis and the subsequent treatment, as in the case of phenylketonuria.

References (58)

  • S. Mangold et al.

    Cerebral folate deficiency: a neurometabolic syndrome?

    Mol Genet Metab

    (2011)
  • F. Nasrallah et al.

    Creatine and creatine deficiency syndromes: biochemical and clinical aspects

    Pediatr Neurol

    (2010)
  • O. Fattal et al.

    Review of the literature on major mental disorders in adult patients with mitochondrial diseases

    Psychosomatics

    (2006)
  • M.D. Cappellini et al.

    Glucose-6-phosphate dehydrogenase deficiency

    Lancet

    (2008)
  • R.I. Kelley

    Inborn errors of cholesterol biosynthesis

    Adv Pediatr

    (2000)
  • L. Kanner

    Autistic disturbances of affective contact

    Nervous Child

    (1943)
  • M. Rutter et al.

    Autism and known medical conditions: myth and substance

    J Child Psychol Psychiatry

    (1994)
  • T. Pampols

    Inherited metabolic rare disease

    Adv Exp Med Biol

    (2010)
  • J.M. Saudubray et al.

    Clinical approach to treatable inborn metabolic diseases: an introduction

    J Inherit Metab Dis

    (2006)
  • F.N. Sedel et al.

    Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults

    J Inherit Metab Dis

    (2007)
  • Y. Estrov et al.

    Psychiatric symptoms of inherited metabolic disease

    J Inherit Metab Dis

    (2000)
  • N. Zecavati et al.

    Neurometabolic disorders and dysfunction in autism spectrum disorders

    Curr Neurol Neurosci Rep

    (2000)
  • M.H. Al-Owain et al.

    Map of autosomal recessive genetic disorders in Saudi Arabia: concepts and future directions

    Am J Med Genet A

    (2012)
  • A. Ververi et al.

    Clinical and laboratory data in a sample of Greek children with autism spectrum disorders

    J Autism Dev Disord

    (2011)
  • E.M. Dykens et al.

    Medical conditions associated with autism

  • B. Manzi et al.

    Autism and metabolic diseases

    J Child Neurol

    (2008)
  • G. Novarino et al.

    Mutations in BCKD-kinase lead to a potentially treatable form of autism with epilepsy

    Science

    (2012)
  • J.J. Mitchell

    Phenylalanine hydroxylase deficiency

  • C.H. Chen et al.

    A Chinese classic phenylketonuria manifested as autism

    Br J Psychiatry

    (1989)
  • Cited by (49)

    • Neurological evaluation and management of autism spectrum disorder

      2020, Rosenberg’s Molecular and Genetic Basis of Neurological and Psychiatric Disease: Volume 1
    • Genetic mechanisms of regression in autism spectrum disorder

      2019, Neuroscience and Biobehavioral Reviews
      Citation Excerpt :

      However, inborn errors of metabolism, such as those leading to biological pathway dysfunctions within cellular organelles – mitochondria, peroxisomes, lysosomes – or to defective energy source metabolism – lipids, proteins, carbohydrates – should be considered potential causes of unexpected regression (Rice and Steiner, 2016). These genetic disorders are not covered by this review but their connection to ASD has been summarized elsewhere (Ghaziuddin and Al-Owain, 2013). This review aims to describe the evidence for genetic influences in regressive ASD and summarize the rates of the regression phenotype within carriers of ASD-associated gene variants.

    View all citing articles on Scopus
    View full text